– USA, CA – Masimo Corporation (Nasdaq: MASI), a leading global medical innovator, announced the appointments of Tim Scannell and Wendy Lane to its Board of Directors, effective immediately, bringing the Board to eight members.
“We are pleased to welcome Tim and Wendy as our newest independent directors. Both are high-caliber professionals who will bring critical perspectives to the Board and possess expertise that closely aligns with our key focus areas. Tim’s background leading highly successful commercial organizations in the medical technology sector – including during his time as President and Chief Operating Officer of Stryker Corporation – will make him an ideal fit immediately. Wendy’s vast experience overseeing corporate governance changes and serving in board leadership roles will be highly additive as we refocus the organization. We look forward to working alongside Tim and Wendy as we capitalize on the exciting opportunities ahead for Masimo and position the Company for continued growth.” said Lead Independent Director, Quentin Koffey.
About Timothy J. Scannell
Tim Scannell brings over 30 years of experience and success delivering market-leading results from his leadership roles at Stryker Corporation (NYSE: SYK), one of the world’s leading medical technology companies. He served as President and COO of Stryker from 2018 to 2021, overseeing all of Stryker’s commercial businesses and regions globally. Before this, he served as group president for Stryker’s MedSurg & Neurotechnology businesses for ten years.
Tim Scannell serves as a director and non-executive chairman of the board of directors for Insulet Corporation (Nasdaq: PODD), a medical device company, and serves on the board of Novocure Limited (Nasdaq: NVCR). Tim Scannell also serves on the boards of several private companies including Regenity Biosciences, Synaptive Medical, and CereVasc, Inc.
Tim Scannell said, “It’s an honor to be joining Masimo’s Board. I believe strongly in the Company’s mission and have long admired its accomplishments and focus on innovation. I look forward to drawing on my experience to help Masimo deliver even better outcomes for patients, employees and shareholders.”
Tim Scannell attended the University of Notre Dame, where he received a Bachelor’s degree in Business Administration and Marketing and his Master of Business Administration.
About Wendy E. Lane
Wendy Lane has served on the boards of 16 companies over the past 32 years and, on those boards, she has sat on and/or chaired seven audit committees, as well as compensation, nominating/governance, strategic alternatives, and other committees. She has served as Chair of Lane Holdings, Inc., a private equity investment company, since 1992.
Wendy Lane serves as a director of Verisk Analytics, Inc. (Nasdaq: VRSK), a data, analytics, and risk assessment firm, YourBio Health, Inc., a blood collection technology and devices venture, and CAC Holdings, LLC, an insurance broker. She served on the boards of directors of Envestnet, Inc. (NYSE: ENV), NextPoint Financial, Inc., CoreLogic, Inc., Willis Towers Watson PLC (Nasdaq: WTW); MSCI Inc. (NYSE: MSCI); UPM-Kymmene Oyj, and Laboratory Corporation of America Holdings (NYSE: LH).
Wendy Lane was also a Principal and Managing Director of Donaldson, Lufkin, and Jenrette Securities Corporation and, before that, was an investment banker at Goldman, Sachs & Co.
Wendy Lane said, “I am excited to work alongside Masimo’s other talented directors as we chart the course forward for the Company. I have deep respect for the Masimo team’s work, which has improved the lives of countless individuals, and I am eager to be a part of the Company’s next chapter.”
Ms. Lane holds a B.A. from Wellesley College in Mathematics and French and an M.B.A. from Harvard Business School.
About Masimo
Masimo is a global medical technology company that develops and produces various industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and automation and connectivity solutions. In addition, Masimo Consumer Audio is home to eight legendary audio brands, including Bowers & Wilkins, Denon, Marantz, and Polk Audio. Our mission is to improve life, improve patient outcomes, and reduce the cost of care.
For more: https://www.masimo.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.